Skip to main content
SpringerLink
Log in

Topiramate

As Monotherapy in Newly Diagnosed Epilepsy

  • Adis Drug Profile
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

▴ Topiramate is an antiepileptic drug that has a broad spectrum of antiseizure effects, which appear to be the result of several neurostabilising pharmacological mechanisms. These include blockade of ion channels, potentiation of GABA neuroinhibition and glutamate receptor antagonism at non-NMDA receptors, as well as mild inhibition of carbonic anhydrase.

▴ Topiramate monotherapy dose dependently reduced the number of patients who met seizure related exit criteria in children (aged ≥6 years) and adults with epilepsy.

▴ This effect was also observed in patients who had previously experienced partial onset seizures and for those who had experienced generalised tonic clonic seizures. Six-month and 1-year seizure-free rates were dose-dependently reduced.

▴ In epilepsy, topiramate monotherapy 100 or 200 mg/day was as effective as carbamazepine 600 mg/ day or valproate 1250 mg/day as measured by time to study exit for any reason, time to first seizure and percentage of patients seizure-free in the final 6 months of treatment (mean treatment duration 244 days).

▴ Adverse events associated with topiramate monotherapy that were dosage related included paraesthesia, weight loss and diarrhoea. Renal calculi were also reported in both fully published trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Notes

  1. .Use of tradenames is for product identification purposes only and does not imply endorsement.

References

  1. Pledger G, Schmidt D. Evaluation of antiepileptic drug efficacy: a review of clinical trial design. Drugs 1994; 48(8): 498–590

    Article  PubMed  CAS  Google Scholar 

  2. Mattson RH. Medical management of epilespy in adults. Neurology 1998 Nov; 51Suppl. 4: 15–20

    Article  Google Scholar 

  3. Mosby’s Drug Consult. Topiramate (3312) [online]. Available from URL: http://www.mosbysdrugconsult.com/ [Accessed 2003 Jun 19]

  4. Ormrod D, McClellan K. Topiramate: a review of its use in childhood epilepsy. Paediatr Drugs 2001; 3(4): 293–319

    Article  PubMed  CAS  Google Scholar 

  5. Gilliam FG, Veloso F, Bomhof MA, et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003 Jan 28; 60(2): 196–202

    Article  PubMed  CAS  Google Scholar 

  6. Langtry H, Gillis J, Davis R. Topiramate: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997 Nov; 54(5): 752–73

    Article  PubMed  CAS  Google Scholar 

  7. Ortho-McNeil Pharmaceutical Inc. Topamax® (topiramate tablets): prescribing Information [online]. Available from URL: http://www.topamax.com/ [Accessed 2003 Jun 19]

  8. Yang Y, Li Q, Shuaib A. Enhanced neuroprotection and reduced hemorragic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuro-pharmacology 2000 Mar; 39(5): 881–8

    CAS  Google Scholar 

  9. Lee S, Kim S, Kim J. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci Lett. 2000 Mar; 281(2): 183–6

    Article  PubMed  CAS  Google Scholar 

  10. Amano K, Hamada K, Yagi K. Antiepileptic effects of topiramate on amygdaloid kindling in rats. Epilepsy Res 1998 Jul; 31(2): 123–8

    Article  PubMed  CAS  Google Scholar 

  11. Sachdeo RC, Sachdeo SK, Levy RH, et al. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients. Epilepsia 2002 Jul; 43(7): 691–6

    Article  PubMed  CAS  Google Scholar 

  12. Pellock J, Neto W, Wu SC, et al. Topiramate plasma concentrations during double-blind monotherapy studies [abstract no. 891172]. Epilepsia 2001; 42Suppl. 7: 212

    Google Scholar 

  13. Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003 Mar; 107(3): 165–75

    Article  PubMed  CAS  Google Scholar 

  14. Rosenfeld W, Doose D, Walker S, et al. Effect of topiramate on the pharmacokinetics of oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia 1997; 38(3): 317–23

    Article  PubMed  CAS  Google Scholar 

  15. Doose D, Wang S, Padmanabhan M, et al. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia 2003; 44(4): 540–9

    Article  PubMed  CAS  Google Scholar 

  16. Arroyo S, Squires L, Wang S, et al. Topiramate: effective as monotherapy in dose-response study in newly diagnosed epilepsy [abstract no. 926953]. Epilepsia 2002; 43Suppl. 7: 241

    Google Scholar 

  17. Kanner AM, Arroyo S, Squires L, et al. Response to topiramate monotherapy in newly diagnosed epilepsy: partial-onset vs. generalized seizures [abstract no. 939333]. Neurology 2003 Mar 11; 60Suppl. 1: 476–7

    Google Scholar 

  18. Ritter F, Gilliam F, Neto W, et al. 1-Year and 2-year seizure remission with topiramate monotherapy in newly/recently diagnosed localization-related epilepsy [abstract no. 891173]. Epilepsia 2001; 42Suppl. 7: 212–3

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adis International Limited, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, Auckland, 1311, New Zealand

    John Waugh & Karen L. Goa

Authors
  1. John Waugh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen L. Goa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Waugh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waugh, J., Goa, K.L. Topiramate. CNS Drugs 17, 985–992 (2003). https://doi.org/10.2165/00023210-200317130-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200317130-00007

Keywords

Search

Navigation